相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood
Xin Chen et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Membrane Tumor Necrosis Factor (TNF) Induces p100 Processing via TNF Receptor-2 (TNFR2)
Hilka Rauert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Unique Phenotype of Human Tonsillar and In Vitro-Induced FOXP3+CD8+ T Cells
Kerstin Siegmund et al.
JOURNAL OF IMMUNOLOGY (2009)
Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
Amit Bar-Or et al.
ANNALS OF NEUROLOGY (2008)
Human Regulatory CD8(+) T Cell The Involvement of Cytokines
Vitaly Ablamunits et al.
Immunology of Diabetes V: From Bench to Bedside (2008)
CD28/CD 154 blockade prevents autoimmune diabetes by inducing nondeletional tolerance after effector T-cell inhibition and regulatory T-cell expansion
Mark R. Rigby et al.
DIABETES (2008)
Rapamycin monotherapy in patients with type 1 diabetes modifies CD4+CD25+FOXP3+ regulatory T-Cells
Paolo Monti et al.
DIABETES (2008)
CD8+regulatory T cells in persistent human viral infections
Eva Billerbeck et al.
HUMAN IMMUNOLOGY (2008)
Anti tumour necrosis-α therapy increases the number of FOXP3+ regulatory T cells in children affected by Crohn's disease
Ida Ricciardelli et al.
IMMUNOLOGY (2008)
Expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells:: Applicability to tumor-infiltrating T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2008)
Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis
Jorge Correale et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function
Aharon Kessel et al.
JOURNAL OF IMMUNOLOGY (2007)
CD8+CD28- T regulatory lymphocytes inhibiting T cell proliferative and cytotoxic functions infiltrate human cancers
Gilberto Filaci et al.
JOURNAL OF IMMUNOLOGY (2007)
Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells
Xin Chen et al.
JOURNAL OF IMMUNOLOGY (2007)
Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4
Simone A. Joosten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Adeno-associated viral vector-mediated interleukin-10 prolongs allograft survival in a rat kidney transplantation model
B. Chen et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
TH-17 cells in the circle of immunity and autoimmunity
Estelle Bettelli et al.
NATURE IMMUNOLOGY (2007)
TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs
B Bisikirska et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
A single course of anti-CD3 monoclonal antibody hOKT3γ1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes
KC Herold et al.
DIABETES (2005)
Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells
MK Levings et al.
BLOOD (2005)
Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody
BJ Hering et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
The role of cytokines (and not only) in inducing and expanding T regulatory type 1 cells
M Battaglia et al.
TRANSPLANTATION (2004)
Treatment of type 1 diabetes with anti-CD3 monoclonal antibody
M Glandt et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2003)
TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes
M Belghith et al.
NATURE MEDICINE (2003)
Generation and function of antigen-specific suppressor and regulatory T cells
N Suciu-Foca et al.
TRANSPLANT IMMUNOLOGY (2003)
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
KC Herold et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Tolerization of dendritic cells by T-S cells: the crucial role of inhibitory receptors ILT3 and ILT4
CC Chang et al.
NATURE IMMUNOLOGY (2002)
NFκB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons
T Yabe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Involvement of nuclear factor-kappa B (NF-κB) activation in mitogen-induced lymphocyte proliferation:: inhibitory effects of lymphoproliferation by salicylates acting as NF-κB inhibitors
L Cavallini et al.
BIOCHEMICAL PHARMACOLOGY (2001)
A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin
DG Alleva et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Suppression of NF-κB activity by sulfasalazine is mediated by direct inhibition of IκB kinases α and β
CK Weber et al.
GASTROENTEROLOGY (2000)
In vitro characterization of five humanized OKT3 effector function variant antibodies
DL Xu et al.
CELLULAR IMMUNOLOGY (2000)